Actavis $21 billion notes issue

3/3/2015
Acquisition finance, Investment grade bond/note issue

$ 21 billion

Completed

3/3/2015


Overview:

  • Actavis has issued $21 billion in notes.
  • This was the second largest such offering in history.
  • The money raised was used to acquire fellow pharmaceutical company Allergan.
  • Cleary Gottlieb Steen & Hamilton (Jeffrey Karpf) and Loyens & Loeff advised Actavis.
  • Cravath Swaine & Moore (Stephen Burns, Andrew Pitts) represented the underwriters, which included JPMorgan, Mizuho Bank, and Wells Fargo.
  • A&L Goodbody and Elvinger Hoss & Prussen also advised the underwriters.

Kurt Stumpo - Journalist - North America and the Caribbean

Jurisdictions:

United States
Ireland

Deal types:

Acquisition finance
Investment grade bond/note issue

Practice area:

Capital markets : Debt

Governing law:

United States

Industry sector:

Pharmaceuticals and life sciences


Firms:

Party: Mizuho Bank (Underwriter)

Party: Wells Fargo Securities (Underwriter)

Party: JPMorgan Chase (Underwriter)


Party: Actavis (Issuer)

Lawyer: Jeffrey Karpf


Party: Mizuho Bank (Underwriter)

Party: Wells Fargo Securities (Underwriter)

Party: JPMorgan Chase (Underwriter)


Party: Mizuho Bank (Underwriter)

Party: Wells Fargo Securities (Underwriter)

Party: JPMorgan Chase (Underwriter)


Party: Actavis (Issuer)